Penneo - Ramping Up Investments
2022-08-30 07:46:00
Redeye retains its positive view of Penneo following its Q2 report despite showing slightly lower ARR growth than expected. However, a highlight was that the FY’22 ARR guidance of DKK 77-82m, corresponding to a 40%-49% y/y growth, as well as the EBITDA guidance of a negative of DKK 15-20m was maintained. Consequently, we make minor 2022E and 2023E forecast adjustments that slightly affect our valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/